Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Furiex Pharmaceuticals, Inc.
| Metric | Furiex Pharmaceuticals, Inc. Healthcare |
|---|---|
| Quality Score | 57 / 100 |
| Revenue (latest) | $39M |
| Net income (latest) | $9M |
| Operating margin | 25.6% |
| Net margin | 22.8% |
| Return on equity | 48.6% |
| Return on assets | 10.1% |
| Return on capital (ROCE) | 15.4% |
| Debt / equity | 3.80× |
| Revenue growth (YoY) | 1386.8% |
| Altman Z″ (distress) | -3.64 |
| Accruals / assets | 36.3% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.